I did some analysis a few weeks ago and ~ 80% of all buying is on liners in nearly all graphite stocks ex SYR which I didn't look at. No Instos playing this space.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor